Iambic Therapeutics is a clinical-stage AI drug discovery company headquartered in San Diego. Its proprietary AI platform pairs the NeuralPLexer 3D generative model for protein-ligand structure prediction with the Enchant multimodal transformer for clinical and preclinical endpoint prediction, integrated with automated wet-lab capabilities. - View it on GitHub